🔥 LATEST: MEI Pharma Goes All-In on Litecoin with $100M Treasury Strategy

In a bold first for public markets, MEI Pharma has raised $100 million to initiate a Litecoin ($LTC) treasury strategy, officially becoming the first publicly traded company to hold LTC on its balance sheet.

This strategic move positions Litecoin as a viable institutional-grade asset, echoing Bitcoin’s earlier adoption trend and signaling growing corporate interest in alternative digital stores of value.